Work

Epstein–Barr Virus Positivity as a Biomarker in First-Line Chemoimmunotherapy for Gastric Cancer

Year: 2027
Type: article
Abstract: Purpose Epstein–Barr virus (EBV)-associated gastric cancer (EBVaGC), which is characterized by an inflamed tumor microenvironment, may represent a relevant subgroup in the setting of immune checkpoint inhibitor (ICI)-based therapy. We evaluated whether EBV positivity identifies a distinct subgroup of gastric cancer in patients receiving first-line chemoimmunotherapy and determined its association with programmed death-ligand 1 (PD-L1) expression and microsatellite instability.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7235582098
Cites: 36
Cited by:
Related to: 10